STX-003

N/A

Report date: 2024/11/20 17:52:22

Base Information

Drug NameSTX-003
Drug Alias NameSTX-003
ClassificationCell and gene therapy > Gene therapy > mRNA
Mechanisms of ActionInterleukin-12 modulators
TargetsInterleukin-12
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesStrand Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesStrand Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A